Skip to content

Tension-balance acupuncture therapy for ischemic stroke spastic paralysis: a clinical evidence-based study

Tension-balance acupuncture therapy for ischemic stroke spastic paralysis: a clinical evidence-based study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085519
Enrollment
Unknown
Registered
2024-06-11
Start date
2024-06-11
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic stroke spastic paralysis

Interventions

:The observation group was treated with tension balance acupuncture combined with new Bobath technology
Control group:the control group was treated with Sham tension balance acupuncture combined with new Bobath technology

Sponsors

The First Hospital of Hunan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? Patients diagnosed with ischemic stroke by CT or MRI, meeting the diagnostic criteria of Chinese and Western medicine for ischemic stroke, and the staging criteria are convalescent; Age 40-80 years old, gender is not limited; ? Improved Ashworth grade =2, Brunnstrom stage II~III; (4) Stable condition (no progress in symptoms and signs within 48 hours, stable vital signs), clear consciousness, able to understand basic instructions, no serious cognitive dysfunction, can cooperate with treatment; (5) No sequelae such as limb paralysis were left after the first onset or previous history of stroke, and no muscle relaxants were used recently; ? Volunteer to participate in the clinical trial research, cooperate with the examination and treatment, and sign the informed consent.

Exclusion criteria

Exclusion criteria: ? Those who do not meet the above diagnostic criteria or inclusion criteria; (2) Patients with severe primary diseases such as heart, lung, liver, kidney, rheumatism, immune, endocrine, or heart, lung, liver, kidney, or brain failure; ? Muscular dystonia not caused by the above cerebrovascular accident; (4) Patients with acupuncture faintness or sustained skin tissue damage, infection, coagulation dysfunction and skin allergy at the acupuncture site; (5) Women who are pregnant or breastfeeding; ? Patients who have used other antispasticity therapy or are participating in other clinical trials or have completed less than 3 months; Note: Patients who meet any of the above criteria will be excluded.

Design outcomes

Primary

MeasureTime frame
Modified Ashworth asticity SCale;

Secondary

MeasureTime frame
Clinical spasticity index,CSI;Fugl-Meyer;Surface electromyography test;Isokinetic muscle strength measurement;Barthel;

Countries

China

Contacts

Public ContactZhou Zhuo

The First Hospital of Hunan University of Chinese Medicine

850446247@qq.com+86 139 7436 0626

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026